Your browser doesn't support javascript.
loading
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer.
Franco-Mateos, Emma; Souza-Egipsy, Virginia; García-Estévez, Laura; Pérez-García, José; Gion, María; Garrigós, Laia; Cortez, Patricia; Saavedra, Cristina; Gómez, Patricia; Ortiz, Carolina; Cruz, Víctor L; Ramos, Javier; Cortés, Javier; Vega, Juan F.
Afiliação
  • Franco-Mateos E; BIOPHYM, Department of Macromolecular Physics, Instituto de Estructura de la Materia, IEM-CSIC, C/Serrano 113 bis, 28006 Madrid, Spain.
  • Souza-Egipsy V; BIOPHYM, Department of Macromolecular Physics, Instituto de Estructura de la Materia, IEM-CSIC, C/Serrano 113 bis, 28006 Madrid, Spain.
  • García-Estévez L; Breast Cancer Department, MD Anderson Cancer Center, 28033 Madrid, Spain.
  • Pérez-García J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Hospital, 08017 Barcelona, Spain.
  • Gion M; Medica Scientia Innovation Research (MedSIR), 08018 Barcelona, Spain.
  • Garrigós L; Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ 07450, USA.
  • Cortez P; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain.
  • Saavedra C; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Hospital, 08017 Barcelona, Spain.
  • Gómez P; IOB, Institute of Oncology, 28007 Madrid, Spain.
  • Ortiz C; Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain.
  • Cruz VL; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Hospital, 08017 Barcelona, Spain.
  • Ramos J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Hospital, 08017 Barcelona, Spain.
  • Cortés J; BIOPHYM, Department of Macromolecular Physics, Instituto de Estructura de la Materia, IEM-CSIC, C/Serrano 113 bis, 28006 Madrid, Spain.
  • Vega JF; BIOPHYM, Department of Macromolecular Physics, Instituto de Estructura de la Materia, IEM-CSIC, C/Serrano 113 bis, 28006 Madrid, Spain.
Int J Mol Sci ; 25(7)2024 Apr 01.
Article em En | MEDLINE | ID: mdl-38612751
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medicamentos Biossimilares / Neoplasias Idioma: En Ano de publicação: 2024 Tipo de documento: Article